JPM-TMT Announces Contract Award for Advanced Development of Broad-spectrum Influenza Drug

Mike Toron
12 years ago

 MediVector, Inc.’s Favipiravir (T-705) targets multiple influenza virus strains  FORT BELVOIR, VA – March 26, 2012.   The Department of Defense’s (DOD) Joint Project Manager Transformational Medical Technologies (JPM-TMT) awarded a $138.5M…

You need a TRAC license to view the rest of this content. Learn more

You need a license to view this content!

TRAC is one of the most comprehensive compendiums of information and analysis of terrorist groups and activities in the world. This level of reporting and analysis requires significant resources to maintain the quality standards TRAC strives for. As such, we require an active licenses to access our extensive content library and research tools.

Verified by MonsterInsights